BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29343528)

  • 1. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy.
    Takamura Y; Shimura M; Katome T; Someya H; Sugimoto M; Hirano T; Sakamoto T; Gozawa M; Matsumura T; Inatani M;
    Br J Ophthalmol; 2018 Oct; 102(10):1351-1357. PubMed ID: 29343528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
    Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
    Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flare levels after intravitreal injection of ranibizumab, aflibercept, or triamcinolone acetonide for diabetic macular edema.
    Morioka M; Takamura Y; Yamada Y; Matsumura T; Gozawa M; Inatani M
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2301-2307. PubMed ID: 30238189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
    Jiang T; Gu J; Zhang P; Chen W; Chang Q
    BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO.
    Kaderli B; Avci R; Gelisken O; Yucel AA
    Int Ophthalmol; 2005 Dec; 26(6):207-14. PubMed ID: 17356929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
    Park DH; Shin JP; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
    BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.
    Maia OO; Takahashi BS; Costa RA; Scott IU; Takahashi WY
    Am J Ophthalmol; 2009 Feb; 147(2):291-297.e2. PubMed ID: 18929352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
    Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
    Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-year follow-up of intravitreal triamcinolone acetonide injection and macular laser photocoagulation for diffuse diabetic macular edema.
    Cho HY; Kang SW; Kim YT; Chung SE; Lee SW
    Korean J Ophthalmol; 2012 Oct; 26(5):362-8. PubMed ID: 23060723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW; Park SC; Cho HY; Kang JH
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane.
    Lai CC; Wang NK; Wu WC; Yeung L; Hwang YS; Chen KJ; Chen TL; Chuang LH
    Cutan Ocul Toxicol; 2011 Dec; 30(4):292-7. PubMed ID: 21449851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
    Hu L; Chen Q; Du Z; Wang W; Zhao G
    Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.
    Choi KS; Chung JK; Lim SH
    Korean J Ophthalmol; 2007 Mar; 21(1):11-7. PubMed ID: 17460426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
    Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
    Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.